Life Sciences Collaborative
The Life Sciences Collaborative (LSC) is a select group of founders and investors that share a common vision for enhancing the success of emerging businesses in the biotechnology, medtech, and digital health sectors through peer-to-peer learning, connecting and building professional relationships.
The Collaborative has built thriving groups over the last ten years in the Princeton, NJ, Philadelphia/King of Prussia, PA, and most recently in Boston, MA, regions all of which are homes to leading life science innovation clusters.
One of the Collaborative’s great strengths is the opportunity for members to build connections across these key regions
Who we are
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors, and industry service providers who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
The meetings also include presentations by emerging companies, providing them with opportunities to get expert feedback on their technologies and to expand their networks.
Mission Statement
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional development and business growth in the Mid-Atlantic Region.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.
OUR MEMBERS
CEOs, Directors, Private Equity and Venture partners, Angel investors. Members may have successful track record leading public or private companies.
Lisa Baskin
Position: Senior Vice President
Categories: 2. PLANNING COMMITTEE, Pennsylvania, senior Vice President
Scheer Partners: Company
Lisa Baskin
Senior Vice President
Melina Blees
Position: Business Operations & Strategy Director
Categories: 3. MEMBERS, Pennsylvania
BioLabs: Company
Melina Blees
Business Operations & Strategy Director
Michael Daley
Principal Consultant
Mike Romano
Position: Partner - Life Science Biopharma Industry Practice Co-Leader
Categories: 2. PLANNING COMMITTEE, Pennsylvania
RSM : Company
Mike Romano
Partner - Life Science Biopharma Industry Practice Co-Leader
Paul Hunter
Position: Vice President, Market Access and Commercial Operations
Categories: 3. MEMBERS, Pennsylvania
Halozyme: Company
Paul Hunter
Vice President, Market Access and Commercial Operations
Rami Levin
Position: Founder & Chief Executive Officer
Categories: 3. MEMBERS, Boston, MA
Rami Levin: The Outcomes Group
Rami is the Founder and CEO of The Outcomes Group, a leadership advisory and executive coaching firm specializing in helping biotech and pharmaceutical leaders scale organizations, navigate strategic inflection points, and unlock their full potential—both professionally and personally.
Drawing on nearly 30 years of leadership experience—including CEO roles at clinical-stage biotech companies, he understands firsthand the unique challenges life sciences executives face, from regulatory complexity and funding constraints to market volatility and organizational scale-up. He’s built companies from the ground up, driven 10x growth in revenue and team size, launched breakthrough therapies globally, raised transformative capital, and negotiated high-impact business development deals.
Rami combines deep industry expertise with proven coaching methodologies to deliver practical strategies and tailored guidance that drive sustainable success. His mission is simple: to empower biotech leaders and teams to achieve lasting business impact while creating balance and fulfillment in their personal lives.
Whether leading a company through critical growth phases, preparing for commercialization, or strengthening executive teams, I partner with leaders to thrive in today’s dynamic life sciences landscape, and to build enduring success beyond it.









